Villous trophoblast in the human placenta consists of a population of
proliferating stem cells which differentiate and individually fuse int
o the syncytiotrophoblast. We studied the apoptotic cascade in this co
mplex epithelial layer by immunohistochemical localization of Fas, Fas
t, Bcl-2, Mcl-1, pro-caspase-3 and caspase-3, T-cell-restricted intrac
ellular antigen-related protein (TIAR), poly(ADP-ribose) polymerase (P
ARP), lamin B, topoisomerase II alpha, and transglutaminase II in cryo
stat and paraffin-fixed tissue sections from, normal human first-trime
ster and term placental villi. The relationship between the apoptotic
cascade and syncytial fusion was studied by coincubation of intact vil
li with FITC-coupled annexin-V, to detect the phosphatidylserine flip,
and propidium iodide, to detect plasma membrane permeability. The fin
al events of the apoptotic cascade were studied by the TUNEL reaction
and ultrastructural appearance of the trophoblast. The phosphatidylser
ine flip was identified in some of the villous cytotrophoblastic cells
, but the presence of both Bcl-2 and Mcl-1 proteins presumably prevent
ed continuation of the apoptotic cascade. The syncytiotrophoblast demo
nstrated heterogeneous findings, suggesting variable progression along
the apoptotic cascade. In some areas Bcl-2 and Mcl-1 predominated, wi
th preservation of the nuclear proteins PARP, lamin B, and topoisomera
se II alpha; in other areas, especially in and around syncytial sprout
s, Bcl-2 and Mcl-1 were absent, accompanied by loss of nuclear protein
s, presence of phosphatidylserine flip, and TUNEL positivity. These da
ta suggest that the apoptotic cascade is initiated in the villous cyto
trophoblast, which in turn promotes syncytial fusion. Donation of anti
-apoptotic proteins into the syncytium, such as Bcl-2 and Mcl-1, focal
ly inhibits further progression along this cascade. Completion of the
apoptotic cascade takes place in and around syncytial sprouts, providi
ng further evidence that these are the sites of trophoblast shedding i
nto the maternal circulation.